TWST News and Press, Twist Bioscience Corporation From 11/15/22

Twist to report fiscal Q4 and full year 2022 financial results before market Friday, November 18, and host a conference call at 8:00 a.m. Eastern Time Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-qualit...

SAN FRANCISCO, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Twist Bioscience Corporation (NASDAQ: TWST) investors who suffered significant losses to submit your losses now . Twist Bioscience Corporation (NASDAQ: TWST) Investigation: Twist claims it is an innovat...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Engineer studio / Shutterstock.com Chinese electric vehicle (EV) stocks are on the move Tuesday as investors react to news of a meeting between President Joe Biden and President Xi Jinping. The two leaders m...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, we’re witnessing an example of how a short report can impact a stock. Reportedly, activist short seller   Scorpion Capital just published a report about Twist Bioscience (NASDAQ: TWST ). You might...

New York, New York--(Newsfile Corp. - November 15, 2022) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Twist Bioscience Corporation ("Twist") common stock (NASDAQ: TWST). Twist is a synthetic biology and genomics company that claims to be deve...

Boston, Massachusetts--(Newsfile Corp. - November 15, 2022) - Block & Leviton is investigating Twist Bioscience Corp. (NASDAQ: TWST) for potential securities law violations. Investors who have lost money in their Twist Bioscience Corp. investment should contact the firm to learn more abo...

Twist Bioscience ( NASDAQ: TWST ) plummeted 26% in premarket trading amid a new short report from Scorpion Capital. Scorpion Capital believes that Twist ( TWST ) will go to zero. Twist ( TWST ) short interest is 11%. Twist ( TWST ) didn't im...

Twist Biosciences ( NASDAQ: TWST ) plummeted 26% amid a new short report from Scorpion Capital. Scorpion Capital believes that Twist ( TWST ) will go to zero. Twist ( TWST ) short interest is 11%. Twist ( TWST ) didn't immediately respond to...

Summary Today, we circle back on Twist Bioscience Corporation for the first time since Spring of this year. This unique biology company is delivering stellar sales growth but continues to have significant cash burn issues despite a rock solid balance sheet. An investment analy...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2022 fourth quarter and full year ended September 3...